Jazz Pharmaceuticals (JAZZ) Debt Ratio (2010 - 2026)

Jazz Pharmaceuticals' Debt Ratio history runs 17 years deep, the most recent figure standing at 0.45 for Q1 2026.

• In Q1 2026, Debt Ratio fell 2.97% year-over-year to 0.45; the TTM figure through Mar 2026 stood at 0.45 (down 2.97% YoY), while the FY2025 annual figure was 0.46, down 9.63% from the prior year.
• Debt Ratio was 0.45 for Q1 2026 at Jazz Pharmaceuticals, down from 0.46 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.55 in Q3 2022 to a low of 0.45 in Q1 2026.
• Historically, Debt Ratio has averaged 0.5 across 5 years, with a median of 0.5 in 2024.
• The sharpest annual moves came in 2022 and 2025: Debt Ratio soared 64.55% in 2022, then declined 9.63% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.53 in 2022, then slipped by 5.09% to 0.5 in 2023, then increased by 1.42% to 0.51 in 2024, then decreased by 9.63% to 0.46 in 2025, then slipped by 1.75% to 0.45 in 2026.
• The last three Debt Ratio figures came in at 0.45 (Q1 2026), 0.46 (Q4 2025), and 0.47 (Q3 2025), per Business Quant data.